Back to Journals » Cancer Management and Research » Volume 11
Original Research
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Is ramucirumab and paclitaxel therapy beneficial for second-line treatment of metastatic gastric or junctional adenocarcinoma for patients with ascites? Analysis of RAINBOW phase 3 trial data
Total article views | HTML views | PDF downloads | Totals | ||
---|---|---|---|---|---|
8,460 | Dovepress* | 7,160+ | 1,112 | 8,272 | |
PubMed Central* | 1,300 | 464 | 1,764 | ||
Totals | 8,460 | 1,576 | 10,036 | ||
*Since 20 March 2019 |
View citations on PubMed and Google Scholar